Cemiplimab
Product Specifications
CAS Number
1801342-60-8
Target
PD-1/PD-L1, Others
Related Pathways
Immunology/Inflammation, Others, Apoptosis, Cell Cycle/Checkpoint
Purity
>97.2%
Bioactivity
Cemiplimab (Anti-Human PD-1) is a human monoclonal antibody that inhibits the PD-1/PD-L1 pathway, serving as a checkpoint inhibitor. It is applicable in research on metastatic cancer and squamous cell skin cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-PLP1-Ra-96Tests 96 Tests
Rat Proteolipid Protein 1, Myelin (PLP1) ELISA Kit
Sign In for Pricing
View Details 